Rui Zeng

699 citations
24 papers · 496 indexed · h-index 8
Topics
Cancer Cells and Metastasis (3 papers)Ferroptosis and cancer prognosis (2 papers)Nanoparticle-Based Drug Delivery (2 papers)
Partner nations
ChinaMalaysiaGermany

In The Last Decade

Rui Zeng

23 papers receiving 493 citations

Peers

Rui Zeng
Comparison fields: 5 of 80
  • Biomedical Engineering 235
  • Molecular Biology 221
  • Biomaterials 145
  • Cancer Research 138
  • Materials Chemistry 61
Replace Shameer Pillarisetti with:
Shameer Pillarisetti South Korea
Haoyu Guo China
Gülşah Erel‐Akbaba Türkiye
Yiwei Peng China
Yingxun Liu China
Qingshuang Tang China
Seok Ho Song South Korea
Ayşe Gülten Kantarcı Türkiye
Rui Zeng relative to Shameer Pillarisetti South Korea Shameer Pillarisetti's profile →
Citations per field
00.5×2.8×
Shameer Pillarisetti · 1×
Citations per year

Countries citing papers authored by Rui Zeng

Since Specialization
Citations

This map shows the geographic impact of Rui Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Zeng more than expected).

Fields of papers citing papers by Rui Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Zeng. The network helps show where Rui Zeng may publish in the future.

Co-authorship network of co-authors of Rui Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Zeng. A scholar is included among the top collaborators of Rui Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Zeng. Rui Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 3
4 1
5 7
6 2
7 2
8 13
9 3
10 11
11 1
12 5
13 18
14 33
15 133
16 9
17 140
18 1
19
LEARNING THROUGH WEB-BASED MULTISTORYLINE CASE STUDIES: A Design-Based Research
4
20
Progress in the signal transduction and biological function of p38γ/SAPK3
1

About Rui Zeng

Rui Zeng is a scholar working on Urology, Developmental Neuroscience and Orthopedics and Sports Medicine, having authored 24 papers that have together received 496 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (3 papers), Ferroptosis and cancer prognosis (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). The work is most often cited by research in Biomaterials (145 citations), Cancer Research (138 citations) and Biomedical Engineering (235 citations). Rui Zeng has collaborated with scholars based in China, Malaysia and Germany. Frequent co-authors include Lu Lu, Ke Li, Kaiyong Cai, Ye He, Zhong Luo, Tiwei Fu, Liangliang Dai, Xiaojing Zhao, Chuanchuan Lin and Bailong Tao. Their work appears in journals such as Proceedings of the National Academy of Sciences, ACS Nano and Biomaterials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026